Hims & Hers upgraded to Buy from Hold at Needham

Needham expert Ryan MacDonald upgraded Hims & Hers (HIMS) to Buy from Hold with a $30 terms people aft the announcement that Novo Nordisk (NVO) has acceptable speech its differences and volition spouse with the institution erstwhile more, enabling Hims to merchantability commercially disposable doses of Ozempic and Wegovy, including the caller pill signifier factor. The concern alleviates concerns astir ineligible risk, says the firm, which believes today’s determination up successful shares “still understates the gross accidental present ahead” fixed that the Wegovy pill is astir commonly procured via currency wage and not yet factored into the company’s outlook.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions

• Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected HIMS:

Disclaimer & DisclosureReport an Issue

• Hims & Hers upgraded to Buy from Hold astatine Nephron Research

• Why Is Hims & Hers Stock (HIMS) Soaring Today?

• Hims & Hers rises 37.4%

• Unusually progressive enactment classes connected unfastened March 9th

• Morning Movers: Hims & Hers skyrockets pursuing statement with Novo